{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:12:18Z","timestamp":1783152738070,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM008396"],"award-info":[{"award-number":["T32 GM008396"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS093175"],"award-info":[{"award-number":["R21NS093175"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS109762"],"award-info":[{"award-number":["R21NS109762"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.bbrc.2019.10.032","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T17:35:27Z","timestamp":1570556127000},"page":"341-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd"],"prefix":"10.1016","volume":"520","author":[{"given":"Monir","family":"Shababi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caley E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayd","family":"Alrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Bryda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian L.","family":"Lorson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2019.10.032_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.10755","article-title":"Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"54","author":"Grohmann","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2019.10.032_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2004-820994","article-title":"Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"35","author":"Rudnik-Schoneborn","year":"2004","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bbrc.2019.10.032_bib3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/302636","article-title":"Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form Is linked to chromosome 11q13-q21","volume":"65","author":"Grohmann","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2019.10.032_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.10182","article-title":"Mapping of autosomal recessive chronic distal spinal muscular atrophy to chromosome 11q13","volume":"51","author":"Viollet","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2019.10.032_bib5","doi-asserted-by":"crossref","first-page":"17463","DOI":"10.1016\/S0021-9258(19)85357-7","article-title":"The human S mu bp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region","volume":"268","author":"Fukita","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2019.10.032_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng703","article-title":"Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1","volume":"29","author":"Grohmann","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2019.10.032_bib7","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddh222","article-title":"Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)","volume":"13","author":"Grohmann","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2019.10.032_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-1119(96)00630-0","article-title":"Evidence for regulation of transcription and replication of the human neurotropic virus JCV genome by the human S(mu)bp-2 protein in glial cells","volume":"185","author":"Chen","year":"1997","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2019.10.032_bib9","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1046\/j.1432-1327.2000.01836.x","article-title":"The rat ortholog of the presumptive flounder antifreeze enhancer-binding protein is a helicase domain-containing protein","volume":"267","author":"Miao","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbrc.2019.10.032_bib10","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/hmg\/ddp134","article-title":"Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery","volume":"18","author":"de Planell-Saguer","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2019.10.032_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-008-0402-7","article-title":"Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease","volume":"87","author":"Guenther","year":"2009","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.bbrc.2019.10.032_bib12","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1093\/hmg\/ddq147","article-title":"Spinal muscular atrophy: mechanisms and therapeutic strategies","volume":"19","author":"Lorson","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2019.10.032_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense oligonucleotide therapies for neurodegenerative diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2019.10.032_bib14","doi-asserted-by":"crossref","first-page":"e2492","DOI":"10.1212\/WNL.0000000000007527","article-title":"Nusinersen in later-onset spinal muscular atrophy: long-term results from the phase 1\/2 studies","volume":"92","author":"Darras","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bbrc.2019.10.032_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mus.26633","article-title":"Nusinersen improves walking distance and reduces fatigue in later-onset SMA","volume":"60","author":"Montes","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbrc.2019.10.032_bib16","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of luxturna (and zolgensma and glybera): where are we, and how did we get here?","author":"Keeler","year":"2019","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.bbrc.2019.10.032_bib17","article-title":"[Gene therapies for neuromuscular diseases]","author":"Saffari","year":"2019","journal-title":"Nervenarzt"},{"key":"10.1016\/j.bbrc.2019.10.032_bib18","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0896-6273(00)80652-2","article-title":"Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele","volume":"21","author":"Cox","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2019.10.032_bib19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/mt.2016.33","article-title":"Rescue of a mouse model of spinal muscular atrophy with respiratory distress type 1 by AAV9-IGHMBP2 is dose dependent","volume":"24","author":"Shababi","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2019.10.032_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.omtm.2018.08.005","article-title":"A\u00a0direct comparison of IV and ICV delivery methods for gene replacement therapy in a mouse model of SMARD1","volume":"10","author":"Shababi","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.bbrc.2019.10.032_bib21","first-page":"1","article-title":"Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model","author":"Nizzardo","year":"2015","journal-title":"Science Advances"},{"key":"10.1016\/j.bbrc.2019.10.032_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2006.01.012","article-title":"Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector","volume":"14","author":"Baughan","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2019.10.032_bib23","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.mt.6300222","article-title":"Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing","volume":"15","author":"Coady","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbrc.2019.10.032_bib24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.yjmcc.2012.01.005","article-title":"Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy","volume":"52","author":"Shababi","year":"2012","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2019.10.032_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12031-011-9614-3","article-title":"Optimization of SMN trans-splicing through the analysis of SMN introns","volume":"46","author":"Shababi","year":"2012","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.bbrc.2019.10.032_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89970","article-title":"Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy","volume":"2","author":"Kaifer","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2019.10.032_bib27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddx434","article-title":"Selective vulnerability in neuronal populations in nmd\/SMARD1 mice","volume":"27","author":"Villalon","year":"2018","journal-title":"Hum. Mol. Genet."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19319217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X19319217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:55:33Z","timestamp":1777384533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X19319217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0006291X19319217"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.032","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}